Which antibiotic protects stem cell patients best? new study pits cipro against levo

NCT ID NCT03850379

Completed Disease control Sponsor: Henry Ford Health System Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 308 adults getting a stem cell transplant for blood cancer. Researchers compared two antibiotics, ciprofloxacin and levofloxacin, to see which one better prevents bacterial infections after transplant. The goal is to find the best option to keep patients safe during recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: antibiotics (ciprofloxacin and levofloxacin)
What this could lead to: If one antibiotic works better, it could reduce infections and improve recovery for stem cell transplant patients.
What could go wrong: This is a small, completed Phase 2 study, so results may not apply to all patients. Both drugs have known side effects like tendon issues or heart rhythm changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROPHYLAXIS STEM CELL TRANSPLANT COMPLICATIONS

Contacts and locations

Locations

Henry Ford

Detroit, Michigan, 48202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.